Cell cycle regulator expression after coronary stenting in humans.

Area of Science:

• Cardiovascular Biology
• Cell Cycle Regulation
• Vascular Biology

Background:

• Vascular smooth muscle cell (VSMC) proliferation, driven by growth factors, is crucial in restenosis after coronary angioplasty.
• Current treatments aim to inhibit VSMC proliferation by targeting cell cycle regulators.
• Histopathological data on cell cycle regulator expression post-human coronary stenting is limited.

Purpose of the Study:

• To investigate the expression of key cell cycle regulators and growth factors in human coronary arteries following stent implantation.
• To correlate the expression patterns of these molecules with neointima formation and VSMC proliferation.

Main Methods:

• Post-mortem human coronary arteries (n=31) from 23 cadavers were analyzed.
• Tissue sections were stained for platelet-derived growth factor (PDGF), basic fibroblast growth factor (b-FGF), cyclin D1, p16, p21, p27, and macrophage colony stimulating factor receptor (MCSF-R).
• MCSF-R staining was used to identify dedifferentiated VSMCs.

Main Results:

• MCSF-R-positive cells (dedifferentiated VSMCs) were present in neointima, decreasing over time.
• PDGF was detected in neointima and showed a gradual decrease.
• Cyclin D1 expression correlated with VSMC proliferation, while p27 was downregulated during proliferation and upregulated later.

Conclusions:

• Cyclin D1 and p27 expression levels are significantly associated with neointimal proliferation after coronary stenting.
• Modulating p27 levels or inhibiting cyclin D1 may offer therapeutic strategies to prevent excessive neointima formation.